On Tuesday a US administrative-law judge believes that Apple Inc. infringed a Qualcomm Inc. patent and that certain iPhone models should be banned from entering the US, but a final ruling from the International Trade Commission in a separate case went Apple’s way, reported the Wall Street Journal.
Apple gained a win with a ruling by members of the US International Trade Commission that the iPhone maker didn’t violate a patent held by its former chip supplier. That ruling effectively overturned an ITC administrative judge’s finding in September that Apple had violated a Qualcomm patent related to power efficiency in mobile phones.
Hours earlier a US trade judge recommended Qualcomm be granted a request for an import ban on some iPhones sold by Apple. An administrative law judge of the US International Trade Commission said the basis for the ban was a finding that Apple infringed a Qualcomm patent relating to smartphone technology.
“We appreciate Judge McNamara’s recognition of Apple’s infringement of our hardware patent and that she will be recommending an import ban and cease and desist order,” Qualcomm General Counsel Don Rosenberg said in a statement.
“Qualcomm is using these cases to distract from having to answer for the real issues, their monopolistic business practices,” Apple said in a statement.
In both cases Qualcomm sought to have imports of Apple Inc iPhone 7, 8 and X models containing chips made by Intel Corp banned. Because iPhones are made overseas, banning imports would choke Apple’s sales of the phones in the United States.
Full Content: Wall Street Journal & Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Fortnite Returns to Apple’s U.S. App Store After Five-Year Ban
May 21, 2025 by
CPI
Federal Court to Hear Case on Trump’s Firing of FTC Democrats
May 20, 2025 by
CPI
UK Government Suffers Third Successive Defeat on Data (Use and Access) Bill
May 20, 2025 by
CPI
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas